Author

Anna-Maija Sulonen

Observed names: A. Sulonen, Sulonen, Anna-Maija

Institutions: University of Helsinki, Institute for Molecular Medicine Finland, HiLIFE – Elämäntieteiden Instituutti

Observed institutions: University of Helsinki, Finnish Institute for Health and Welfare, Institute for Molecular Medicine Finland, HiLIFE – Elämäntieteiden Instituutti

ORCID: 0000-0002-5518-1975

Observed ORCID: 0000-0002-5518-1975

OpenAlex ID: A5038245668

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

2011 · Stephen Sawcer, Maria Ban, et al. · Nature · 2,762

Comparison of solution-based exome capture methods for next generation sequencing

2011 · Anna-Maija Sulonen, Pekka Ellonen, et al. · Genome biology · 269

Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene

2010 · Eveliina Jakkula, Virpi Leppä, et al. · The American Journal of Human Genetics · 249

mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis

2008 · Xinhua Yu, Dirk Koczan, et al. · PLoS ONE · 76

No evidence for shared etiology in two demyelinative disorders, MS and PLOSL

2008 · Anna-Maija Sulonen, Suvi P. Kallio, et al. · Journal of Neuroimmunology · 9

Haplotype information of large neuromuscular disease genes provided by linked-read sequencing has a potential to increase diagnostic yield

2024 · Johanna Lehtonen, Anna-Maija Sulonen, et al. · Scientific Reports · 2

Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction

2025 · Johanna Lehtonen, Anna H Hakonen, et al. · Human Molecular Genetics

P.295Linked-read whole genome sequencing in patients with congenital myopathy

2019 · J. Lehtonen, V. Lehtokari, et al. · Neuromuscular Disorders

Copy number variations in multiple sclerosis

2014 · Sulonen, Anna-Maija · Työväentutkimus Vuosikirja

Works count: 9

Citation count: 3,367

H-index: 5

I10-index: 4